-
Brazil Faces Debt and Inflation Test as Lula Prepares Fourth Term
-
Canada Signals Openness to Chinese Automakers if US Trade Talks Fail
-
Canada Expands Asian Trade Push as US Negotiations Resume
-
US Mortgage Rate Falls for Fourth Week but Remains Above 7%
-
US Jobless Claims Rise to 200,000 but Layoffs Remain Historically Low
-
Italy Raises 2026 Growth View but Warns Energy Will Keep Inflation High
-
Godzilla Minus Zero Review: Takashi Yamazaki’s Anti-Nuclear Allegory
-
Euro-Area Growth Slows to 0.4% While Employment Stalls
-
DA Demands No-Work-No-Pay for Striking Municipal Workers in Coalition Talks
-
UK Economy Grows 0.7% in Third Quarter as Services Lead Expansion
-
US Wholesale Inflation Eases Monthly but Hits a Four-Year Annual High
-
India's Retail Inflation Reaches 6.09% as Food Prices Accelerate
-
India's Wholesale Inflation Jumps to 12.29% as Fuel Costs Surge
-
Malta Emerges as Premier Low-Season Destination for UK Travelers
-
China's October Activity Data Reveal a Weak Start to the Fourth Quarter
-
Japan's Economy Edges Into Contraction as Costly Oil Weighs on Demand
-
Philippines Urges ASEAN and China to Accelerate South China Sea Code of Conduct
-
UK Home Asking Prices Drop £6,745 in November Amid High Mortgage Rates
-
Mbeki Claims No Progress Since 2018; Author Cites Infrastructure and Economic Gains
-
Alex Georgiev Sets Personal Record to Win NCAA Pole Vault at Penn Relays
-
Qatar's Amir and Venezuelan Acting President Discuss Energy Cooperation
-
Arctaris Impact Investors Invests $21M of Preferred Equity in Charlotte, NC Multifamily Opportunity Zone Property
-
Sharecare Partners With HomeTown Health to Bring AskMD, Funded Through the GREAT Health Program, to More Rural Hospitals and Patients Across Georgia
-
Wi2Wi Reports 35% Revenue Growth to US$2.36M and Returns to Profitability with US$268K Net Income in Q3 2026
-
Ainos Reports Third Quarter 2026 Results and Highlights Expanding AI Nose Commercial Momentum
-
SMX Brings a New Level of Transparency to Gold Trading Through trueGold Technology
-
Westell Technologies, Inc. Announces Its Commencing a Tender Offer
-
Rescue Intellitech Expands Professional Decontamination Portfolio for Fire Departments with DeconWasher(TM) Pro S
-
MicroVision Lidar Powers Commercial Driverless Trucking at Scale with Kodiak AI
-
Expecting a Refund but Owe Back Taxes? Clear Start Tax Explains How the IRS Offset Program Takes It First
-
Gladstone Capital Corporation Earnings Call and Webcast Information
-
Cardiff Lexington Announces Third Quarter 2026 Financial Results
-
SMX: The Future of Gold Will Be Defined by What We Know About It -Powering Verified Trade and Tokenisation
-
NuRAN Wireless Eliminates Floating-Price Preferred Overhang and Locks In a Fixed C$1.20 Conversion Price
-
GameSquare Holdings Reports 2026 Third Quarter Results with Revenue up 77% YoY and Net Income Reaches $10.1 Million
-
ValorPay UAB Goes Live on T2, the Eurosystem's Real-Time Settlement System
-
CNS Pharmaceuticals Reports Third Quarter 2026 Financial Results and Highlights Progress in Establishing Transformative Therapeutic Pipeline
-
XCF Global Reports Third Quarter 2026 Financial Results & Affirms 2027 Outlook
-
NextSource Materials Appoints Eugene Lee as Chief Financial Officer
-
International Battery Metals Ltd. Reports Second Quarter of Fiscal Year 2027 Financial Results
-
Abasca Resources Engages Northern Arc Public Affairs to Advance Federal Engagement on the Loki Flake Graphite Project
-
AsiaFIN Holdings Corp. Announces Third Quarter 2026 Results, Reporting Strong Nine-Month Financial Performance with Improved Margins
-
Thalia Therapeutics PLC Announces Promising Interim Phase I Data for miRisten in AML
-
Strategic Metals Reports Promising Results From the Rusty and Ranch Projects
-
Golden Minerals Reports Third Quarter 2026 Financial Results
-
OBI Pharma Signs Collaboration and License Agreement with Novartis
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 16
-
Blue Chip Capital Group Announces Quotation of its Common Stock on the OTCID and Updates Status of Initial Regulatory Compliance
-
RenX Enterprises Reports Record Third Quarter Revenue of $4.49 Million, Up 27.6% Year Over Year
-
Sebring Design Build Wins Best Universal Design in the 2026 KBB Awards for a Franklin Primary Bath
DEA BUSTED!! While Chinese Marijuana Cartels Spread Right Under DEA's Nose, FDA CANNABIS RESEARCH BLOCKED
While Chinese cartels built a marijuana empire across at least six states, MMJ-a Rhode Island-based company with FDA orphan drug status-was left to rot in a bureaucratic black hole engineered by DEA Diversion officials Matthew Strait, Thomas Prevoznik, Anne Milgram and Aarathi Haig.
WASHINGTON, D.C. / ACCESS Newswire / July 1, 2025 / Just nine days after MMJ BioPharma Cultivation publicly exposed the DEA's failure to act on sprawling Chinese-backed illegal marijuana grows, the agency finally made headlines launching raids on massive criminal cannabis operations in Oklahoma tied to Chinese nationals. The bust involved over 40,000 plants, firearms, and cartel-style logistics.
But this long-overdue enforcement action raises a disturbing question:

Why has the DEA prioritized foreign crime syndicates only after years of silence and why is it still blocking a federally-compliant company like MMJ from advancing FDA authorized medical research?
DEA Ignored Foreign Criminal Networks Until Publicly Shamed
MMJ BioPharma Cultivation warned of DEA inaction over CCP linked marijuana grows on June 18, 2025. Just nine days later, the DEA moved in Oklahoma raiding what officials described as one of the largest criminal marijuana networks in U.S. history. The target: a Chinese syndicate with ties to the United Front Work Department (UFWD), the CCP's global influence arm.
"DEA had time to delay a law-abiding FDA-regulated company, but no time to shut down transnational farms tied to COMMUNIST CHINESE PARTY front groups. That's not just negligence; it's national security malpractice."
- Duane Boise, CEO, MMJ BioPharma Cultivation
While Chinese cartels built a marijuana empire across at least six states, MMJ, a Rhode Island-based company with FDA orphan drug status, was left to rot in a bureaucratic black hole engineered by DEA Diversion officials Matthew Strait, Thomas Prevoznik, Anne Milgram, and Aarathi Haig.
Science Stifled, Crime Rewarded
For over 2,390 days, MMJ has complied with every federal requirement to grow marijuana for clinical trials targeting Huntington's Disease and Multiple Sclerosis. But instead of supporting medical innovation, the DEA:
Ignored timelines under its own regulations
Forced MMJ into unconstitutional ALJ proceedings
Withheld a valid Order to Show Cause remedy
Allowed foreign criminal groups to operate unimpeded in the meantime
Supreme Court: DEA's Legal System Was Illegal
In a pair of landmark rulings, Axon v. FTC and Jarkesy v. SEC, the U.S. Supreme Court deemed the DEA's in-house judge system unconstitutional. These were the very proceedings used to sabotage MMJ's progress.
The Department of Justice has since abandoned the defense of these cases, leaving DEA Diversion leadership exposed for systemic abuse of power.
Florida Hemp Stats Show DEA Failure
A study by the Florida Department of Agriculture found:
64% of hemp-derived products were actually illegal marijuana
44% contained toxic pesticides
DEA enforcement? Zero.
Meanwhile, lab-made THC analogs like Delta-8, HHC, and THC-A are sold on every street corner without oversight, while MMJ's tightly controlled FDA pathway remains blocked.
DEA Must Now Face the Real Questions
With Matthew Strait quietly retiring under a cloud of scandal and Anne Milgram already gone, pressure mounts on Deputy Administrator Thomas Prevoznik, the architect of the cannabis blockade.
Incoming DEA Administrator Terrance Cole has a moment of reckoning:
Will he fix the agency or protect its worst actors?
MMJ and the Path Forward
If the DEA truly wants to reclaim its credibility, it must:
Immediately approve MMJ's registration
Audit Diversion Control Division corruption
End all ALJ hearings on cannabis licensing
Transfer cannabis oversight to FDA/NIH
Prosecute-not promote-DEA staff who obstructed medical research
Final Word
The DEA's sudden action on Chinese organized crime proves one thing: they can act when the pressure is real. MMJ's warnings, backed by years of compliance and legal action, helped trigger a long-overdue enforcement response.
But busting Chinese gangs isn't enough. It's time the DEA stops being the enemy of American science.
Until MMJ BioPharma Cultivation gets the registration it lawfully earned, and patients gain access to cannabinoid therapies they desperately need, the DEA's War on Medical Cannabis continues.
MMJ is represented by attorney Megan Sheehan
CONTACT:
Madison Hisey
[email protected]
203-231-8583
SOURCE: MMJ International Holdings
View the original press release on ACCESS Newswire
P.Smith--AT